Pfizer, DHL Global Forwarding Japan and All Nippon Airways (ANA) has commenced distribution of COVID-19 vaccines under a joint partnership for the international transportation of vaccines between Belgium and Japan.
While there are a number of key challenges involved in the transportation and distribution of vaccines and other pharmaceutical supplies, Pfizer, DHL and ANA respectively boast exceptional track record in the delivery of pharmaceutical goods, and have jointly established a reliable and efficient operation structure for the vaccine delivery from Belgium to Japan.
Pfizer, over 60 years in Japan, brings therapies to people that extend and significantly improve their lives applying science and our global resources. The vaccine, which is based on BioNTech’s proprietary mRNA technology, was developed by both BioNTech and Pfizer.
Under the terms of the final agreement signed by MHLW and Pfizer Japan Inc., approximately 144 million doses of this vaccine will be supplied to Japan in 2021.
